Sophie C. Wehenkel

Manipulating T lymphocyte homing and activation for cancer immunotherapy

Sophie C. Wehenkel, 2015 .

Purity of transferred CD8+ T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1

K. Ladell, G. Dolton, J. Hindley, 2016, Immunology and cell biology.

SHP-1: the next checkpoint target for cancer immunotherapy?

A. Ager, H. Watson, Sophie C Wehenkel, 2016, Biochemical Society transactions.

ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells

K. Ladell, G. Dolton, M. Kashiwagi, 2019, Scientific Reports.

ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells

Hideaki, Nagase, K. Ladell, 2019, Scientific Reports.

Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells

A. Ager, H. Watson, Rebar N. Mohammed, 2016, Biochemical Society transactions.

ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells

K. Ladell, G. Dolton, M. Kashiwagi, 2019, Scientific Reports.